VCV002203027.3 - ClinVar

NM_002437.5(MPV17):c.461+1G>C

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_002437.5(MPV17):c.461+1G>C

Variation ID: 2203027 Accession: VCV002203027.3

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 2p23.3 2: 27311898 (GRCh38) [ NCBI UCSC ] 2: 27534766 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Feb 8, 2023	Oct 8, 2024	Sep 7, 2022

HGVS

Nucleotide	Protein	Molecular consequence
NM_002437.5:c.461+1G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.		splice donor
NM_002437.4:c.461+1G>C
NC_000002.12:g.27311898C>G
NC_000002.11:g.27534766C>G
NG_008075.1:g.15666G>C
NG_008075.2:g.16199G>C
NG_033055.1:g.1365G>C
NG_033055.2:g.1547G>C

... more HGVS ... less HGVS

Protein change

Other names

Canonical SPDI

NC_000002.12:27311897:C:G

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
MPV17		-	-	GRCh38 GRCh37	320	350

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not provided	Pathogenic (1)	criteria provided, single submitter	Sep 7, 2022	RCV002651443.3
MPV17-related disorder	Pathogenic (1)	no assertion criteria provided	Jun 19, 2024	RCV004733604.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Pathogenic (Sep 07, 2022)	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) Method: clinical testing	not provided Affected status: unknown Allele origin: germline	Labcorp Genetics (formerly Invitae), Labcorp Accession: SCV003523968.2 First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024	Publications: PubMed (5) PubMed: 19520594‚ 17576681‚ 9536098‚ 31664948‚ 23714749 Comment: For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MPV17 protein in which other variant(s) (p.Ser170Phe) have … (more) For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MPV17 protein in which other variant(s) (p.Ser170Phe) have been observed in individuals with MPV17-related conditions (PMID: 19520594). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Studies have shown that disruption of this splice site alters MPV17 gene expression (PMID: 31664948). Disruption of this splice site has been observed in individuals with Mitochondrial DNA depletion syndrom (PMID: 23714749, 31664948). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 7 of the MPV17 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. (less)
Pathogenic (Jun 19, 2024)	no assertion criteria provided Method: clinical testing	MPV17-related condition Affected status: unknown Allele origin: germline	PreventionGenetics, part of Exact Sciences Accession: SCV005362388.1 First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024	Comment: The MPV17 c.461+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the homozygous … (more) The MPV17 c.461+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the homozygous state to be causative for mitochondrial DNA depletion syndrome (Uusimaa et al. 2014. PubMed ID: 23714749; Mahjoub et al. 2019. PubMed ID: 31664948). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice donor site in MPV17 are expected to be pathogenic. This variant is interpreted as pathogenic. (less)

Comment:

For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MPV17 protein in which other variant(s) (p.Ser170Phe) have been observed in individuals with MPV17-related conditions (PMID: 19520594). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Studies have shown that disruption of this splice site alters MPV17 gene expression (PMID: 31664948). Disruption of this splice site has been observed in individuals with Mitochondrial DNA depletion syndrom (PMID: 23714749, 31664948). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 7 of the MPV17 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product.

Comment:

The MPV17 c.461+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the homozygous state to be causative for mitochondrial DNA depletion syndrome (Uusimaa et al. 2014. PubMed ID: 23714749; Mahjoub et al. 2019. PubMed ID: 31664948). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice donor site in MPV17 are expected to be pathogenic. This variant is interpreted as pathogenic.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series.	Mahjoub G	BMC medical genetics	2019	PMID: 31664948
Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.	Uusimaa J	European journal of human genetics : EJHG	2014	PMID: 23714749
Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II.	Kaji S	Molecular genetics and metabolism	2009	PMID: 19520594
Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.	Buratti E	Nucleic acids research	2007	PMID: 17576681
Statistical features of human exons and their flanking regions.	Zhang MQ	Human molecular genetics	1998	PMID: 9536098

Text-mined citations for this variant ...

Record last updated Oct 13, 2024

ClinVar Genomic variation as it relates to human health

NM_002437.5(MPV17):c.461+1G>C

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...